// App-Quantinova.ai

: Oral Antiviral Therapy and Monoclonal Antibody for the Treatment of COVID-19 Infection in Outpatients Receiving Anti-Cancer Treatment for Hematological Malignancies: A Multicenter Prospective Study Exploring Efficacy, Safety and Predictors of COVID-19 Lung Failure

Researchers

Presenter

  • Carla Minoia

Principal Investigators

  • Davide Bavaro

  • Giacomo Loseto

  • Crescenza Pasciolla

  • Lucia Diella

  • Carmen Pelligrino

  • Valentina Totaro

  • Vito Spada

  • Michele Camporeale

  • Immacolata Attolico

  • Tommasina Perrone

  • Felice Clemente

  • Francesco di Gennaro

  • Pellegrino Musto

  • Attilio Guarini

  • Annalisa Saracino

Medical Centers

  • Hematology Unit, University of Bari, Bari, Italy

  • Hematology and Cell Therapy Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Oncology (ONC)

Disease

  • Hematological malignancies

  • Coronavirus disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Ritonavir

Outcome

  • N/A

Study Design

  • Efficacy

  • Safety

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved